Sylvain Simon

1.4k total citations
19 papers, 523 citations indexed

About

Sylvain Simon is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Sylvain Simon has authored 19 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Immunology and 5 papers in Biomedical Engineering. Recurrent topics in Sylvain Simon's work include CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (7 papers) and Nanowire Synthesis and Applications (5 papers). Sylvain Simon is often cited by papers focused on CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (7 papers) and Nanowire Synthesis and Applications (5 papers). Sylvain Simon collaborates with scholars based in United States, France and Germany. Sylvain Simon's co-authors include Nathalie Labarrière, Virginie Vignard, Amir Khammari, François Lang, Brigitte Dréno, Didier Guillemot, Philippe Weber, Emmanuelle Varon, Cécile Laurent and Hervé Lecœur and has published in prestigious journals such as Blood, Cancer Cell and Cancer Research.

In The Last Decade

Sylvain Simon

19 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvain Simon United States 10 331 282 107 61 45 19 523
Emily Han-Chung Hsiue Taiwan 13 215 0.6× 126 0.4× 102 1.0× 88 1.4× 83 1.8× 24 431
Odelia Amit Israel 13 278 0.8× 59 0.2× 92 0.9× 44 0.7× 38 0.8× 39 525
Elham Askari Iran 10 345 1.0× 115 0.4× 252 2.4× 40 0.7× 20 0.4× 29 651
Manoj Chelvanambi United States 8 349 1.1× 467 1.7× 398 3.7× 47 0.8× 64 1.4× 15 858
Sarah Mertlitz Germany 9 114 0.3× 125 0.4× 59 0.6× 18 0.3× 14 0.3× 13 273
Kristina Berg Lorvik Norway 11 355 1.1× 495 1.8× 189 1.8× 52 0.9× 52 1.2× 15 741
Mark Jacobs United States 8 219 0.7× 177 0.6× 150 1.4× 72 1.2× 27 0.6× 10 506
Ester Blanco Spain 12 398 1.2× 302 1.1× 115 1.1× 28 0.5× 78 1.7× 31 611
Valentina La Sorsa Italy 9 218 0.7× 399 1.4× 62 0.6× 67 1.1× 35 0.8× 13 600
Miriam Echaide Spain 11 296 0.9× 239 0.8× 90 0.8× 22 0.4× 54 1.2× 24 474

Countries citing papers authored by Sylvain Simon

Since Specialization
Citations

This map shows the geographic impact of Sylvain Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Simon more than expected).

Fields of papers citing papers by Sylvain Simon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Simon. The network helps show where Sylvain Simon may publish in the future.

Co-authorship network of co-authors of Sylvain Simon

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Simon. A scholar is included among the top collaborators of Sylvain Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Simon. Sylvain Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Simon, Sylvain, Anusha Rajan, Longhui Zeng, et al.. (2025). Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy. Nature Cancer. 6(4). 647–665. 6 indexed citations
2.
Coffey, David G., Pınar Ataca Atilla, Erden Atilla, et al.. (2024). Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy. Blood. 145(2). 220–233. 6 indexed citations
3.
Asen, Theresa, Wenshi Wang, Anindita Chakraborty, et al.. (2024). CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells. Frontiers in Immunology. 15. 1340619–1340619. 4 indexed citations
4.
Shabaneh, Tamer B., Andrew R. Stevens, Ekram Gad, et al.. (2024). Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. Journal for ImmunoTherapy of Cancer. 12(2). e008566–e008566. 19 indexed citations
5.
Rulli, Samuel, et al.. (2024). Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes. OncoImmunology. 13(1). 2376782–2376782. 4 indexed citations
6.
Coffey, David G., Ola Landgren, Andrew J. Cowan, et al.. (2023). Impact of Gamma-Secretase Inhibition on the Multiple Myeloma Immune Microenvironment. Blood. 142(Supplement 1). 4683–4683. 1 indexed citations
7.
Atilla, Pınar Ataca, Sylvain Simon, Erden Atilla, et al.. (2023). Trogocytosis May Attenuate the Efficacy of Anti-BCMA CAR T Cells Administered in Combination with γ-Secretase Inhibitor. Blood. 142(Supplement 1). 2083–2083. 1 indexed citations
8.
Simon, Sylvain, et al.. (2023). Multispecific Hybrid T Cell Receptors for Sensitive Targeting of Cancer. Blood. 142(Supplement 1). 4822–4822. 1 indexed citations
9.
Simon, Sylvain, et al.. (2022). Synthetic HLA-independent T cell receptors for cancer immunotherapy. Cancer Cell. 40(4). 359–361. 2 indexed citations
10.
Simon, Sylvain, et al.. (2021). Synthetic receptors for logic gated T cell recognition and function. Current Opinion in Immunology. 74. 9–17. 11 indexed citations
11.
Dréno, Brigitte, Amir Khammari, Virginie Vignard, et al.. (2021). Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients. Cancer Immunology Immunotherapy. 70(10). 3015–3030. 11 indexed citations
12.
Bechara, Rami, et al.. (2021). French club of Young Immunologists: One year and counting. European Journal of Immunology. 51(8). 1879–1881. 1 indexed citations
13.
Simon, Sylvain, Sébastien Gouard, Nicolas Chouin, et al.. (2021). Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model. Cancers. 13(6). 1256–1256. 9 indexed citations
14.
Simon, Sylvain, Virginie Vignard, Jean-Baptiste Alberge, et al.. (2020). Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. Journal for ImmunoTherapy of Cancer. 8(1). e000311–e000311. 25 indexed citations
15.
Simon, Sylvain, Zhong Wu, Virginie Vignard, et al.. (2018). TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features. Frontiers in Immunology. 9. 1962–1962. 11 indexed citations
16.
Simon, Sylvain, Virginie Vignard, Émilie Varey, et al.. (2017). Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy. Cancer Research. 77(24). 7083–7093. 17 indexed citations
17.
Simon, Sylvain & Nathalie Labarrière. (2017). PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?. OncoImmunology. 7(1). e1364828–e1364828. 265 indexed citations
18.
Simon, Sylvain, Virginie Vignard, Brigitte Dréno, et al.. (2015). PD-1 expression conditions T cell avidity within an antigen-specific repertoire. OncoImmunology. 5(1). e1104448–e1104448. 48 indexed citations
19.
Guillemot, Didier, Emmanuelle Varon, Claire Bernède, et al.. (2005). Reduction of Antibiotic Use in the Community Reduces the Rate of Colonization with Penicillin G--Nonsusceptible Streptococcus pneumoniae. Clinical Infectious Diseases. 41(7). 930–938. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily Han-Chung Hsiue Breakdown of academic impact, for papers by Odelia Amit Breakdown of academic impact, for papers by Elham Askari Breakdown of academic impact, for papers by Manoj Chelvanambi Breakdown of academic impact, for papers by Sarah Mertlitz Breakdown of academic impact, for papers by Kristina Berg Lorvik Breakdown of academic impact, for papers by Mark Jacobs Breakdown of academic impact, for papers by Ester Blanco Breakdown of academic impact, for papers by Valentina La Sorsa Breakdown of academic impact, for papers by Miriam Echaide
Rankless by CCL
2026